Debt-to-equity of NEUROCRINE BIOSCIENCES INC from 31 Mar 2012 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NEUROCRINE BIOSCIENCES INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 31 Dec 2025.
  • NEUROCRINE BIOSCIENCES INC Debt-to-equity for the quarter ending 31 Dec 2025 was 43%, a 16% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NEUROCRINE BIOSCIENCES INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 43% +5.9% +16% 31 Dec 2025
Q3 2025 44% +6% +16% 30 Sep 2025
Q2 2025 41% -0.32% -0.77% 30 Jun 2025
Q1 2025 38% -6.2% -14% 31 Mar 2025
Q4 2024 38% -5% -12% 31 Dec 2024
Q3 2024 38% -2.8% -7% 30 Sep 2024
Q2 2024 41% +1.4% +3.4% 30 Jun 2024
Q1 2024 44% +4.2% +11% 31 Mar 2024
Q4 2023 42% -0.31% -0.72% 31 Dec 2023
Q3 2023 41% -5.3% -12% 30 Sep 2023
Q2 2023 40% -9.2% -19% 30 Jun 2023
Q1 2023 40% -12% -24% 31 Mar 2023
Q4 2022 43% -8.9% -17% 31 Dec 2022
Q3 2022 46% -6.5% -12% 30 Sep 2022
Q2 2022 49% -11% -18% 30 Jun 2022
Q1 2022 52% -14% -22% 31 Mar 2022
Q4 2021 52% -25% -33% 31 Dec 2021
Q3 2021 52% -39% -43% 30 Sep 2021
Q2 2021 59% -36% -38% 30 Jun 2021
Q1 2021 66% -39% -37% 31 Mar 2021
Q4 2020 77% -38% -33% 31 Dec 2020
Q3 2020 91% -24% -21% 30 Sep 2020
Q2 2020 96% -21% -18% 30 Jun 2020
Q1 2020 105% -12% -10% 31 Mar 2020
Q4 2019 114% +0.32% +0.28% 31 Dec 2019
Q3 2019 115% -2.2% -1.9% 30 Sep 2019
Q2 2019 117% -4.6% -3.8% 30 Jun 2019
Q1 2019 117% -3.2% -2.6% 31 Mar 2019
Q4 2018 114% +13% +13% 31 Dec 2018
Q3 2018 118% +44% +59% 30 Sep 2018
Q2 2018 122% +78% +179% 30 Jun 2018
Q1 2018 120% +106% +726% 31 Mar 2018
Q4 2017 101% +88% +663% 31 Dec 2017
Q3 2017 74% +62% +500% 30 Sep 2017
Q2 2017 44% +32% +280% 30 Jun 2017
Q1 2017 15% +3.9% +37% 31 Mar 2017
Q4 2016 13% +3.2% +31% 31 Dec 2016
Q3 2016 12% +1.9% +18% 30 Sep 2016
Q2 2016 11% +0.25% +2.2% 30 Jun 2016
Q1 2016 11% -1.8% -15% 31 Mar 2016
Q4 2015 10% -4.5% -31% 31 Dec 2015
Q3 2015 10% -5.6% -35% 30 Sep 2015
Q2 2015 11% -7.3% -39% 30 Jun 2015
Q1 2015 12% -10% -44% 31 Mar 2015
Q4 2014 15% -14% -48% 31 Dec 2014
Q3 2014 16% -12% -42% 30 Sep 2014
Q2 2014 19% -11% -37% 30 Jun 2014
Q1 2014 22% -9.6% -30% 31 Mar 2014
Q4 2013 28% -8.7% -24% 31 Dec 2013
Q3 2013 28% -24% -46% 30 Sep 2013
Q2 2013 29% -43% -59% 30 Jun 2013
Q1 2013 32% -86% -73% 31 Mar 2013
Q4 2012 37% 31 Dec 2012
Q3 2012 51% 30 Sep 2012
Q2 2012 72% 30 Jun 2012
Q1 2012 118% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.